These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1934454)
41. ["Eosinophilia-myalgia" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases]. Castot A; Bidault I; Bournerias I; Carlier P; Efthymiou ML Therapie; 1991; 46(5):355-65. PubMed ID: 1754978 [TBL] [Abstract][Full Text] [Related]
42. AHR activation by tryptophan--pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome? Rieber N; Belohradsky BH Immunol Lett; 2010 Feb; 128(2):154-5. PubMed ID: 19941898 [TBL] [Abstract][Full Text] [Related]
43. [Polyneuropathy and fasciitis in eosinophilia-myalgia syndrome]. Hetzel W; Dangel P; Molitor H Fortschr Neurol Psychiatr; 1991 Oct; 59(10):425-31. PubMed ID: 1662183 [TBL] [Abstract][Full Text] [Related]
44. Chronic fatigue: a peculiar evolution of eosinophilia myalgia syndrome following treatment with L-tryptophan in four Italian adolescents. Priori R; Conti F; Luan FL; Arpino C; Valesini G Eur J Pediatr; 1994 May; 153(5):344-6. PubMed ID: 8033924 [TBL] [Abstract][Full Text] [Related]
45. Eosinophilic cholecystitis as a possible late manifestation of the eosinophilia-myalgia syndrome. Hepburn A; Coady A; Livingstone J; Pandit N Clin Rheumatol; 2000; 19(6):470-2. PubMed ID: 11147758 [TBL] [Abstract][Full Text] [Related]
46. L-tryptophan-induced eosinophilia-myalgia syndrome. I. Report of two cases with pseudoxanthoma-elasticum-like skin changes. Mainetti C; Schmied E; Masouyé I; Chavaz P; Saurat JH Dermatologica; 1991; 183(1):57-61. PubMed ID: 1769422 [TBL] [Abstract][Full Text] [Related]
47. Eosinophilia-myalgia syndrome: coming to grips with a new illness. Kilbourne EM Epidemiol Rev; 1992; 14():16-36. PubMed ID: 1289111 [TBL] [Abstract][Full Text] [Related]